Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

118 results about "Hospital stay" patented technology

Sliding positioning guide device

The invention discloses a sliding positioning guide device which comprises an arc-shaped fixing arm including an arc-shaped chute, an arc-shaped sliding arm matched with the arc-shaped chute, a positioning puncture needle matched with a positioning needle and a skeleton fixing part installed in a drill bit sleeve. The starting end of the arc-shaped fixing arm is provided with the drill bit sleeve radially extending along the arc-shaped fixing arm, and the drill bit sleeve is provided with a fixing screw for fixing the drill bit sleeve. The tail end of the fixing arm is provided with a fixing screw for fixing the sliding arm in the arc-shaped chute, the tail end of the sliding arm is provided with the positioning needle radially extending along the arc-shaped sliding arm, and the positioning needle is provided with a fixing screw for fixing the positioning needle. The arc-shaped fixing arm and the arc-shaped sliding arm are con-cyclic, the skeleton fixing part and the positioning needle are located on the same horizontal plane, and the skeleton fixing part installing the drill bit sleeve and the positioning needle encounter at the center of the circle. The sliding positioning guide device is simple in structure, convenient to operate and capable of accurately and rapidly enabling a drill bit or a guide needle to penetrate an appropriate position, reduces secondary operation injury on local soft tissues, shortens the operation time, reduces bleeding, reduces complications of postoperative patients and shortens the hospital stays.
Owner:田红波 +2

Compositions and methods related to heart failure

The invention provides methods for (a) prolonging time to hospitalization for heart failure; (b) prolonging time to first hospitalization for heart failure; (c) reducing the total number of days a patient with heart failure spends in the hospital for heart failure for a single hospital stay (i.e., reducing the duration of a single hospital stay for a patient with heart failure); (d) reducing the total number of days a patient spends in the hospital for heart failure for multiple hospital stays (i.e., two or more hospital stays); (e) reducing the number of hospital admissions for heart failure; (f) reducing mortality and reducing hospitalizations for heart failure (e.g., the total number of days in the hospital and / or the number of hospital visits); (g) increasing the left ventricular ejection fraction in a heart failure patient; (h) treating a sexual dysfunction (e.g., erectile dysfunction and female sexual dysfunction) (j) treating a headache in a heart failure patient by administering a non-steroidal antiinflammatory compound (i.e., NSAIDs); (k) treating a heart failure patient who has a history of hypertension (but who is not currently diagnosed with hypertension); (l) improving the quality of life in a heart failure patient based on the Minnesota Living with heart failure questionnaire; (m) decreasing the levels of B-type natriuretic peptide; (n) treating hypertension in a heart failure patient; (o) lowering blood pressure in a heart failure patient; (p) treating labile hypertension; (q) treating idiopathic hypertension; (r) increasing patient compliance with medication dosing in a heart failure patient; (s) treating hypertension in a patient with a dilated heart; (t) treating ischemic disease and / or coronary artery disease; and (u) reducing cardiomegaly in a patient in need thereof comprising administering to the patient a therapeutically effective amount of (i) a hydralazine compound or pharmaceutically acceptable salt thereof, (ii) isosorbide dinitrate and / or isosorbide mononitrate, and (iii) optionally at least one compound selected from the group consisting of angiotensin converting enzyme inhibitors, β-adrenergic antagonists, angiotensin II antagonists, aldosterone antagonists, cardiac glucosides (digitalis), and diuretic compounds.
Owner:NITROMED

Auxiliary incision-free anus cannula device

ActiveCN103948404ATo achieve the purpose of minimally invasiveBeautiful abdominal woundGuide needlesSurgical needlesSurgical operationInjury mouth
The invention discloses an auxiliary incision-free anus cannula device, relates to a peritoneoscope surgical operation auxiliary instrument and provides an auxiliary incision-free anus cannula device which has the advantages that no scar is left on the abdomen, the postoperative pain is reduced to the greatest extent, the length of stay is shortened, the expense is reduced and the like. The auxiliary incision-free anus cannula device is provided with an outer cannula, a guide tube, a rear cover and an apparatus hole cover, wherein external threads are formed at the tail end of the outer cannula; the outer cannula sleeves the guide tube; internal threads which are formed at the rear cover are in threaded connection with the external threads at the tail end of the outer cannula; a conical part is arranged at the front end of the guide tube; a grip handle is arranged at the rear end of the guide tube; an apparatus hole is formed in the tail of the rear cover; internal threads at the apparatus hole cover are in threaded connection with external threads at the tail of the rear cover. A peritoneoscope lower left colon and rectum resection operation is completed without an abdomen wall auxiliary incision, the minimally invasive aim is achieved, an abdomen wound is more attractive, the occurrence of postoperative incisional hernia, incision infection, dehiscence, incision tumour abdomen wall plantation and the like is avoided, and the intestinal canal adhesion probability is reduced. The auxiliary incision-free anus cannula device has the advantages that tumour-free operation is realized, the operation is simple and convenient, and safety and reliability are realized.
Owner:ZHONGSHAN HOSPITAL XIAMEN UNIV

Method for preparing atomized liquid for treating infantile asthmatic suffocating pneumonia

The invention discloses a method for preparing atomized liquid for treating infantile asthmatic suffocating pneumonia. The atomized liquid comprises gleditsia fruit, loquat leaf, European hop flower, Chinese waxgourd semen, common bluebeard herb, platycodon root, red clover, whiteflower hogfennel root and borneol which serve as raw materials. The method is characterized by comprising the following steps of: (1) extracting the loquat leaf, the European hop flower and the common bluebeard herb by a supercritical fluid extraction method to obtain volatile oil; (2) crushing the gleditsia fruit and the borneol into superfine powder; (3) decocting the red clover, the whiteflower hogfennel root, the Chinese waxgourd semen and the platycodon root in water twice, filtering, mixing filtrates, and concentrating at the temperature of 80 DEG C until the relative density is 1.1 to obtain a water extracting solution; and (4) stirring the volatile oil obtained in the step (1), the superfine powder obtained in the step (2) and the water extracting solution obtained in the step (3) uniformly, standing at normal temperature for 12 hours, and filtering to obtain liquid medicine. Clinical experiments prove that the atomized liquid prepared by the method has an obvious treatment effect, and the hospital stays can be shortened.
Owner:南通东湖国际旅行社有限公司

Compound maltodextrin fructose beverage, preparation method thereof and application thereof

The invention provides a compound maltodextrin fructose beverage. Each liter of compound maltodextrin fructose beverage comprises, by weight, 100-110 g of maltodextrin, 10-20 g of crystalline fructose, 2.0-3.0 g of sodium citrate, 3.0-4.0 g of potassium citrate, 0.1-0.2 g of sweetening agent, 0.2-0.3 g of vitamin C, pH modifier, and the balance water, wherein the dosage of the pH modifier follows the standard of making the pH of the compound maltodextrin fructose beverage be 4.7-5.0. The compound maltodextrin fructose beverage contains carbohydrates and vitamin C, the energy of the beverage is high, and the beverage is rich in nutrition. The invention further provides a method for preparing the compound maltodextrin fructose beverage. The preparation method is simple and easy to operate. The compound maltodextrin fructose beverage is suitable for being drunk by a patient before an operation, so that the patient's energy storage under the conditions of an empty stomach is improved, the carbohydrate metabolism is maintained, postoperation insulin resistance is reduced, pre-operation thirst, hunger and anxiety are relieved, the patient's postoperation subjective symptom improvement awareness is improved, the thin and weak patient's weight loss is reduced, and hospital stay is shortened.
Owner:深圳前海大健康家医疗管理有限公司

Wisdom medical platform for preventing gastroesophageal reflux and realization method for platform

The invention discloses a wisdom medical platform for preventing gastroesophageal reflux and a realization method for the platform. The platform comprises a wearable monitoring terminal, a wireless transmission module and a wisdom medical monitoring software system, wherein the wearable monitoring terminal and the wisdom medical monitoring software system are both connected with the wireless transmission module; an airbag is mounted on the outer side wall of a stomach tube; and a pressure pump is mounted outside the stomach tube and connected with the airbag. Family members of patients or medical monitoring personnel are notified in first time after the gastroesophageal reflux occurs through the wisdom medical monitoring software system, so that the real-time property is good, and higher safety and high efficiency are achieved; and a home, community and hospital integrated remote monitoring system is constructed based on a PC end, a cloud end and a mobile terminal, so that the patients or old people can be remotely monitored, more dysphagia patients or more nasal feeding old people can safely return to the society to perform community or home health care, the hospitalization time is shortened, and medical resources are saved. The platform can be widely applied to the field of medical electronics.
Owner:GUANGZHOU GENERAL HOSPITAL OF GUANGZHOU MILITARY COMMAND

Fracture rib bone setting device system for thoracoscope

PendingCN109820588AIt is not easy to be affected by the movement of the back muscles to produce segmental displacementImprove experienceInternal osteosythesisBone platesEngineeringHospital stay
The invention discloses a fracture rib bone setting device system for a thoracoscope. The system comprises a fracture bone setting plate body, fixing claws and thread-carrying self-locking tying belts; multiple first fixing holes and multiple second fixing holes are formed in the two sides of the fracture bone setting plate body at intervals, and multiple first fixing grooves and multiple second fixing grooves are formed in the edges of the two sides of the fracture bone setting plate body at intervals; the fixing claws are used for being clamped among the first fixing grooves and the second fixing grooves; the thread-carrying self-locking tying belts are used for penetrating into the first fixing holes and the second fixing holes to fix the fracture bone setting plate body in the rib bones. Through the mode, the system can fix the fracture rib bones under the thoracoscope while conducting thoracic exploration operative treatment on severe thoracic traumas with rib fracture at many parts, the operation process is simplified to a certain extent, opportunities can also be created for a patient with bone fracture at the back rib bones, thus the rehabilitation process of the patient isquicker, the occurrence probability of complications relevant to rib fracture is lowered, the hospital stay time is shortened, and the system is expected to increase the curative rate for clinical rib fracture thoracic injuries.
Owner:GUANGDONG NO 2 PROVINCIAL PEOPLES HOSPITAL
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products